Improved health and survival of FIV-infected cats is associated with the presence of autoantibodies to the primary receptor, CD134

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 47, 2009, Pages 19980-19985

  Grant, Chris K ^a   Fink, Elizabeth A ^b   Sundstrom, Magnus ^b   Torbett, Bruce E ^b   Elder, John H ^b  

^a Custom Monoclonals International   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Antireceptor antibody; Autoantibody; FIV; Lentivirus; Virus neutralization

Indexed keywords

AUTOANTIBODY; CD134 ANTIGEN; EPITOPE; MEMBRANE PROTEIN; RECEPTOR ANTIBODY; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; CAT DISEASE; CELL SURFACE; CONTROLLED STUDY; CORONAVIRUS; EX VIVO STUDY; EXPERIMENTAL INFECTION; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA VIRUS; FLUORESCENCE ACTIVATED CELL SORTING; HEALTH; HEALTH STATUS; HERPES VIRUS; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; RNA VIRUS; SURVIVAL; VESIVIRUS; VIRUS INFECTION; VIRUS LOAD;

ANIMALS; AUTOANTIBODIES; CATS; CELL LINE; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; RECEPTORS, OX40; SURVIVAL RATE; T-LYMPHOCYTES; VIRAL LOAD; VIRUS INTERNALIZATION;

ANIMALIA; CALICIVIRIDAE; CORONAVIRUS; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELINE LEUKEMIA VIRUS; HERPESVIRIDAE; LENTIVIRUS; RNA VIRUSES;

EID: 73949127150     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0911307106     Document Type: Article

References (45)

1. Pedersen NC (1993) The feline immunodeficiency virus. The Retroviridae, ed Levy JA (Plenum Press, New York), Vol 2, pp 181-228.
2. O'Neil LL, Burkhard MJ, Diehl LJ, Hoover EA (1995) Vertical transmission of feline immunodeficiency virus. AIDS Res Hum Retroviruses 11:171-182.
3. O'Neil LL, Burkhard MJ, Hoover EA (1996) Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats. J Virol 70:2894-2901.
4. Obert LA, Hoover EA (2000) Feline immunodeficiency virus clade C mucosal transmission and disease courses. AIDS Res Hum Retroviruses 16:677-688.
5. Rogers AB, Hoover EA (1998) Maternal-fetal feline immunodeficiency virus transmission: Timing and tissue tropisms. J Infect Dis 178:960-967.
6. English RV, Nelson P, Johnson CM, Nasisse M, Tompkins MB (1994) Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J Infect Dis 170:543-552.
7. Bach JM, et al. (1994) Early stages of feline immunodeficiency virus infection in lymph nodes and spleen. AIDS Res Hum Retroviruses 10:1731-1738.
8. Beebe AM, et al. (1994) Primary stage of feline immunodeficiency virus infection: Viral dissemination and cellular targets. J Virol 68:3080-3091.
9. Callanan JJ, Racz P, Thompson H, Jarrett O (1993) Morphologic Characterization of the Lymph Node Changes in Feline Immunodeficiency Virus Infection as an Animal Model of AIDS (S. Karger, Basel), pp 115-136.
10. Parodi AL, Femenia F, Moraillon A, Crespeau F, Fontaine JJ (1994) Histopathological changes in lymph nodes of cats experimentally infected with the feline immunodeficiency virus (FIV). J Comp Pathol 111:165-174.
11. Rideout BA, Lowensteine LJ, Hutson CA, Moore PF, Pedersen NC (1992) Characterization of morphologic changes and lymphocyte subset distribution in lymph nodes from cats with naturally acquired feline immunodeficiency virus infection. Vet Pathol 29:391-399.
12. Woo JC, Dean GA, Pedersen NC, Moore PF (1997) Immunopathologic changes in the thymus during the acute stage of experimentally induced feline immunodeficiency virus infection in juvenile cats. J Virol 71:8632-8641.
13. Dow SW, Poss ML, Hoover EA (1990) Feline immunodeficiency virus: A neurotropic lentivirus. J Acquir Immune Defic Syndr 3:658-668.
14. Prospero-Garcia O, Criado JR, Henriksen SJ (1994) Pharmacology of ethanol and glutamate antagonists on rodent sleep: A comparative study. Pharmacol Biochem Behav 49:413-416.
15. Lafrado L, et al. (1993) FIV: Amodel for retrovirus-induced pathogenesis. AIDS Res Rev 3:115-150.
16. Phillips TR, et al. (1994) Neurological abnormalities associated with feline immunodeficiency virus infection. J Gen Virol 75(Pt 5):979-987.
17. Phillips TR, et al. (1996) Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR. J Neurovirol 2:388-396.
18. Prospero-Garcia O, et al. (1994) Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc Natl Acad Sci USA 91:12947-12951.
19. Prospero-Garcia O, et al. (1994) Intraventricular administration of a FIV-envelope protein induces sleep architecture changes in rats. Brain Res 659:254-258.
20. Hurtrel B, et al. (1994) Early events in lymph nodes during infection with SIV and FIV. Res Virol 145:221-227.
21. Pancino G, et al. (1993) Structure and variations of feline immunodeficiency virus envelope glycoproteins. Virology 192:659-662.
22. Shelton GH, et al. (1990) Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: A retrospective study (1968-1988). J Acquir Immune Defic Syndr 3:623-630.
23. Shimojima M, et al. (2004) Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 303:1192-1195.
24. de Parseval A, Chaterji U, Sun P, Elder JH (2004) Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc Natl Acad Sci USA 101:13044-13049.
25. de Parseval A, et al. (2005) Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus. Nat Struct Mol Biol 12:60-66.
26. Corre JP, Fevrier M, Chamaret S, Theze J, Zouali M (1991) Anti-idiotypic antibodies to human anti-gp120 antibodies bind recombinant and cellular human CD4. Eur J Immunol 21:743-751.
27. Willett BJ, Hosie MJ (1999) The role of the chemokine receptor CXCR4 in infection with feline immunodeficiency virus. Mol Membr Biol 16:67-72.
28. de Parseval A, Grant CK, Sastry KJ, Elder JH (2006) Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): Soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope. J Virol 80:3088-3091.
29. Sundstrom M, et al. (2008) Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein. J Virol 82:9134-9142.
30. Fontenot JD, Hoover EA, Elder JH, Montelaro RC (1992) Evaluation of feline immunodeficiency virus and feline leukemia virus transmembrane peptides for serological diagnosis. J Clin Microbiol 30:1885-1890.
31. Reubel GH, et al. (1992) Interaction of acute feline herpesvirus-1 and chronic feline immunodeficiency virus infections in experimentally infected specific pathogen free cats. Vet Immunol Immunopathol 35:95-119.
32. Shelton GH, Waltier RM, Conner SC, Grant CK (1989) Prevalence of feline immunodeficiency virus and feline leukemia virus infections in pet cats. J Am Animal Hosp Assoc 25:7-12.
33. de Parseval A, Elder JH (2001) Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: Role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor. J Virol 75:4528-4539.
34. de Rozieres S, et al. (2004) Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3. Retrovirology 1:38.
35. Grant CK (1995) Immunoglobulin changes associated with feline immunodeficiency virus infections. Feline Immunology and Immunodeficiency, eds Willett BJJ, Jarrett O, Jarrett O (Oxford Univ Press), pp 170-189.
36. Chams V, Jouault T, Fenouillet E, Gluckman JC, Klatzmann D (1988) Detection of anti-CD4 autoantibodies in the sera of HIV-infected patients using recombinant soluble CD4 molecules. AIDS 2:353-361.
37. Moore JP, Sattentau QJ, Clapham PR (1990) Enhancement of soluble CD4-mediated HIV neutralization and gp 120 binding by CD4 autoantibodies and monoclonal antibodies. AIDS Res Hum Retroviruses 6:1273-1279.
38. Wilks D, et al. (1990) Anti-CD4 autoantibodies and screening for anti-idiotypic antibodies to anti-CD4 monoclonal antibodies in HIV-seropositive people. AIDS 4:113-118.
39. Pastori C, et al. (2006) Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: A possible protective effect against disease progression. Blood 107:4825-4833.
40. Barassi C, et al. (2005) Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy. J Virol 79:6848-6858.
41. Kuwata T, et al. (2009) Association of progressive CD4(+) T cell decline in SIV infection with the induction of autoreactive antibodies. PLoS Pathog 5:e1000372.
42. Phillips TR, et al. (1990) Comparison of two host cell range variants of feline immunodeficiency virus. J Virol 64:4605-4613.
43. Grant CK, Essex M, Gardner MB, Hardy WD, Jr (1980) Natural feline leukemia virus infection and the immune response of cats of different ages. Cancer Res 40:823-829.
44. Callanan JJ, et al. (1992) Clinical and pathological findings in feline immunodeficiency virus experimental infection. Vet Immunol Immunopathol 35:3-13.
45. Lillie JW, Green MR (1989) Transcription activation by the adenovirus E1a protein. Nature 338:39-44.